Rafferty Asset Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-149,114
| Closed | -$1.08M | – | 1171 |
|
|
2024
Q3 | $1.08M | Buy |
149,114
+25,855
| +21% | +$187K | ﹤0.01% | 786 |
|
|
2024
Q2 | $1.34M | Sell |
123,259
-269,166
| -69% | -$2.92M | 0.01% | 749 |
|
|
2024
Q1 | $7.35M | Buy |
392,425
+85,511
| +28% | +$1.6M | 0.03% | 369 |
|
|
2023
Q4 | $6.65M | Sell |
306,914
-104,990
| -25% | -$2.28M | 0.03% | 382 |
|
|
2023
Q3 | $8.48M | Buy |
411,904
+273,257
| +197% | +$5.62M | 0.05% | 266 |
|
|
2023
Q2 | $6.52M | Sell |
138,647
-27,084
| -16% | -$1.27M | 0.04% | 356 |
|
|
2023
Q1 | $6.95M | Buy |
165,731
+1,874
| +1% | +$78.6K | 0.05% | 296 |
|
|
2022
Q4 | $6.25M | Sell |
163,857
-1,096
| -0.7% | -$41.8K | 0.05% | 326 |
|
|
2022
Q3 | $6.46M | Buy |
164,953
+67,491
| +69% | +$2.64M | 0.07% | 256 |
|
|
2022
Q2 | $3.15M | Sell |
97,462
-77,086
| -44% | -$2.49M | 0.03% | 380 |
|
|
2022
Q1 | $5.78M | Buy |
174,548
+35,792
| +26% | +$1.18M | 0.03% | 345 |
|
|
2021
Q4 | $5.9M | Buy |
138,756
+65,963
| +91% | +$2.81M | 0.03% | 310 |
|
|
2021
Q3 | $3.23M | Buy |
72,793
+39,819
| +121% | +$1.76M | 0.02% | 436 |
|
|
2021
Q2 | $1.87M | Sell |
32,974
-9,354
| -22% | -$531K | 0.01% | 705 |
|
|
2021
Q1 | $3.17M | Buy |
42,328
+28,826
| +213% | +$2.16M | 0.02% | 454 |
|
|
2020
Q4 | $1.17M | Sell |
13,502
-22,101
| -62% | -$1.91M | 0.01% | 471 |
|
|
2020
Q3 | $2.18M | Buy |
35,603
+9,224
| +35% | +$564K | 0.03% | 393 |
|
|
2020
Q2 | $1.1M | Buy |
+26,379
| New | +$1.1M | 0.02% | 517 |
|
|
2020
Q1 | – | Sell |
-53,837
| Closed | -$3.89M | – | 768 |
|
|
2019
Q4 | $3.89M | Buy |
53,837
+13,276
| +33% | +$958K | 0.06% | 169 |
|
|
2019
Q3 | $5.69M | Buy |
40,561
+12,189
| +43% | +$1.71M | 0.09% | 138 |
|
|
2019
Q2 | $5.2M | Sell |
28,372
-4,492
| -14% | -$822K | 0.09% | 155 |
|
|
2019
Q1 | $5.23M | Buy |
+32,864
| New | +$5.23M | 0.08% | 132 |
|